RHOA and neoplasm: The fact that statins and GGTI inhibitors act upstream of RhoA/ROCK signaling and, thus, have more widespread biochemical effects also appears likely to explain their relative lack of specificity compared to ROCK inhibitors in tumor growth inhibition.